Effect of Cupping Therapy on Nitric Oxide Level in Patients With Cervical Spondylosis

Launched by SHADY ABDELSATTAR REFAAT · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into how cupping therapy might affect the levels of nitric oxide in patients with cervical spondylosis, a condition that can cause neck pain and stiffness. Nitric oxide is a substance in the body that can help with blood flow and pain relief. The study is not yet recruiting participants, but it aims to include both men and women aged between 24 to 60 who have chronic cervical spondylosis and a body mass index (BMI) between 20 and 25.

If you or someone you know is interested in participating, it’s important to note that certain health conditions may exclude you from the study. For example, if you have kidney or liver issues, anemia, skin diseases, or if you are considered morbidly obese (with a BMI over 25), you will not be eligible. Additionally, if you are currently taking medications that might affect pain levels or have other serious health problems, you may not qualify. Participants can expect to learn more about how cupping therapy could potentially help with their condition during the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with (cervical spondylosis) from both sexes.
• • Age range (24-60) in chronic stages.
• • BMI from20-25 kg/m2.
• Exclusion Criteria:
• • Renal and hepatic patients.
• • Anemia, hepatic disease, and dermatological diseases.
• • Morbid obese patients if their BMI exceeds the 25 kg/m2 will be also excluded.
• • the patients are taking any medications known to affect the pain level
• • The patients have a systemic illness, dermatological problems, skin allergy, local ischemic problems